Medscape

Wrist Neuromodulation Device Curbs Essential Tremor

Noninvasive peripheral nerve stimulation applied repeatedly at home over a 3-month period reduced hand tremors in patients with essential tremor (ET), new research shows. In a large prospective study, ...
Yahoo Finance

Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv™Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate ...

Investment accelerates U.S. rollout of a scalable, at-home brain neuromodulation therapy for patients with depression and inadequate response to at least one antidepressant CORAL SPRINGS, Fla., March ...
MedPage Today on MSN

Home-based neuromodulator shows promise for suppressing ventricular arrhythmias

Feasibility of portable stellate ganglion phototherapy device shown in retrospective analy ...
MobiHealthNews

Abbott updates app-based neuromodulation platform with remote programming

Abbott announced today that it has updated NeuroSphere, its app-driven neuromodulation therapy platform, with remote programming capabilities that will allow patients to speak with and receive ...
MedCity News

The role of AI in advancing neuromodulation treatment for epilepsy

Epilepsy is one of the most common neurological diseases, affecting around 50 million people worldwide, and carries a debilitating burden for the patient. It is characterized by recurrent seizures ...
Medical Device Network on MSN

Parkinson’s disease: neuromodulation and the search for disease modification

Neuromodulation is an adjunct to medication for Parkinson’s symptom management, with growing interest in whether it could one ...
Morningstar

Three-Year Data Reinforce Revi® System as the Most Clinically Validated Implantable Tibial Neuromodulation Therapy for Urgency Urinary Incontinence

New data confirm Revi’s unmatched durability, 95% patient satisfaction, and excellent safety over three years, setting a new standard in Implantable Tibial Neuromodulation BlueWind Medical, Ltd., a ...
Nasdaq

Medtronic Receives FDA Approval to Launch Clinical Study for Implantable Tibial Neuromodulation Therapy for Bladder Incontinence

New Investigational Device Aims to Expand Access to Therapy for Patients with Incontinence; Underscores Medtronic's Leadership as Only Company to Offer Neuromodulation Options for Incontinence DUBLIN, ...
Business Wire

Sinaptica Announces Initiation of Co-Development of the SinaptiStim® Precision Neuromodulation System to treat Alzheimer’s Disease; On Track for Pivotal Clinical Trial ...

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sinaptica Therapeutics, Inc., a clinical-stage company leading the development of a new class of personalized neuromodulation therapeutics to treat Alzheimer’s and ...
Nasdaq

Medtronic announces first patient implants of investigational implantable tibial neuromodulation therapy for bladder incontinence

DUBLIN, March 24, 2022 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the first patient implants in the TITAN 2 pivotal study that will evaluate ...
MarketWatch

Neurolief Secures Additional $6 Million Investment Following FDA Approval of Proliv(TM)Rx, Expanding Access to Brain Neuromodulation Therapy for Patients with Inadequate ...

The MarketWatch News Department was not involved in the creation of this content. Investment accelerates U.S. rollout of a scalable, at-home brain neuromodulation therapy for patients with depression ...